Fig. 1 · Structure
Documents & Downloads
AHR 10718
Antiarrhythmic Agent
AHR 10718 is an antiarrhythmic agent that primarily targets cardiac electrophysiology. It effectively suppresses cardiac arrhythmias induced by digitalis intoxication and myocardial infarction, demonstrating significant utility in preclinical models. AHR 10718 is also known to decrease membrane responsiveness and conduction while shortening the effective refractory period in specialized conducting fibers, which can aid in the investigation of cardiac rhythm disorders and arrhythmia treatments.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 96436-73-6 |
| Applications | Antiarrhythmic Agent |
| Formula | C22H35N3O7S |
| Molecular Weight | 485.59 |
| SMILES | OC(/C=C\C(O)=O)=O.CCN(CC)CCNC(N(C(C)C)CCS(=O)(C1=CC=CC=C1)=O)=O |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.